A recent survey by Worldwide Clinical Trials reveals that 62% of respondents are more likely to engage a CRO partner for clinical research than they were five years ago, demonstrating the increasingly vital role that CROs are playing in modern drug development, and the importance of partnering with a CRO that offers medical and scientific expertise.
iPug launches as global digital health company
Medidata, Memorial-Sloan Kettering to expand oncology mHealth use
Mitsubishi Tanabe joins Certara’s Simcyp Consortium
Roivant Sciences, Plexcera form Enzyvant Sciences
The Pulse on Study Conduct by Elizabeth Weeks-Rowe
The monitoring visit report serves a spectrum of integral purposes specific to each monitoring visit type. It is the medium by which all findings identified at monitoring visits, and the status of findings from previous monitoring visits, are documented. It provides conceptual proof of training delivery for initiation visit conduct, and a logistical, clinical and developmental summary recommendation of the investigational site following the pre-study assessment. The closeout visit report signifies closure of investigational sites with submission and signature. The monitoring visit report is the full confirmation of monitoring processes at investigational sites.